日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study

临床早期上皮性卵巢癌淋巴结切除术及生存分析（LILAC）：妇科肿瘤研究协作组（GORILLA-3002）回顾性研究

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2024.35.e75
Yang, Eun Jung; Lee, A Jin; Hwang, Woo Yeon; Chang, Suk-Joon; Kim, Hee Seung; Kim, Nam Kyeong; Kim, Yeorae; Kong, Tae Wook; Lee, Eun Ji; Park, Soo Jin; Son, Joo-Hyuk; Suh, Dong Hoon; Son, Dong Hee; Shim, Seung-Hyuk
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Anticancer Effects of BRD4 Inhibitor in Epithelial Ovarian Cancer

BRD4 抑制剂对上皮性卵巢癌的抗癌作用

期刊:Cancers
影响因子:
doi:10.3390/cancers16050959
Yeorae Kim, Wook-Ha Park, Dong-Hoon Suh, Kidong Kim, Jae-Hong No, Yong-Beom Kim
肿瘤
卵巢癌
发表日期：2024
文献求助 收藏

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer

PD-L1表达在子宫内膜癌患者中的临床意义

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines11102691
Kim, Yeorae; Aiob, Ala; Kim, Hyojin; Suh, Dong Hoon; Kim, Kidong; Kim, Yong Beom; No, Jae Hong
PD-L1
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004)

晚期卵巢癌患者一线 PARP 抑制剂维持治疗失败的风险因素：妇科肿瘤研究协作组研究 (GORILLA-3004)

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.6546
Kim, Nam Kyeong; Kim, Yeorae; Kim, Hee Seung; Park, Soo Jin; Hwang, Dong Won; Lee, Sung Jong; Yoo, Ji Geun; Chang, Suk-Joon; Son, Joo-Hyuk; Kong, Tae-Wook; Kim, Jeeyeon; Shim, Seung-Hyuk; Lee, A Jin; Suh, Dong Hoon; Lee, Yoo-Young
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001)

既往接受过放射治疗的复发性宫颈癌患者，无论是否接受贝伐单抗治疗，发生胃肠道/泌尿生殖系统穿孔和瘘管形成：韩国妇科肿瘤研究协作组（GORILLA）的多中心回顾性研究（GORILLA-1001）

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09695-x
Hwang, Woo Yeon; Chang, Suk-Joon; Kim, Hee Seung; Kim, Nam Kyeong; Kim, Tae Hun; Kim, Yeorae; Kong, Tae Wook; Lee, Eun Ji; Park, Soo Jin; Shim, Seung Hyuk; Son, Joo-Hyuk; Suh, Dong Hoon; Yang, Eun Jung
宫颈癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study

新辅助化疗在晚期子宫内膜癌中的临床意义：一项多中心回顾性队列研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09746-3
Lim, Hyunji; Bang, Seung Hyun; Kim, Yeorae; Cho, Sang Hyun; Shin, Wonkyo; Kim, Se Ik; Kim, Tae Hun; Suh, Dong Hoon; Lim, Myong Cheol; Kim, Jae-Weon
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2022
文献求助 收藏

A rare case of gastric-type mucinous adenocarcinoma in a woman with Peutz-Jeghers syndrome

一例罕见的发生于患有Peutz-Jeghers综合征女性的胃型黏液腺癌病例

期刊:Obstetrics and Gynecology Science
影响因子:1.9
doi:10.5468/ogs.2019.62.6.474
Kim, Yeorae; Kim, Eun Yi; Kim, Tae Jin; Lim, Kyung Taek; Lee, Ki Heon; Chun, Yikyeong; So, Kyeong A
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏